Post-Marketing Surveillance Studies with Expert Guidance
Enhance Product Performance with Navitas’ Post-Marketing Services
Navitas Life Sciences offers comprehensive post-marketing services designed to support the effective commercialization and continued evaluation of your products. Our expertise in post-marketing studies, including Phase IV clinical trials and post-marketing surveillance, enables us to provide critical insights into the long-term safety and efficacy of marketed drugs and medical devices. By utilizing advanced technologies and a local agile delivery model, we help you gather real-world data, assess product performance, and address payer requirements efficiently. Our tailored strategies ensure that you maximize return on investment while minimizing the financial impact of post-approval research.
Maximize ROI and Minimize Costs in Post-Marketing Surveillance
We specialize in a wide range of cost efficient post-marketing services, from project planning and study start-up to data management and biostatistics. Our team provides expert pharmacovigilance and safety reporting, regulatory guidance, and medical writing services, including detailed clinical study reports. Powering Possibilities in end-to-end support or specific standalone post-marketing research to ensure your products continue to meet market and regulatory demands.
Our Post Marketing Clinical Trials support include:





Our key Real World Data and Real World Evidence solutions include:
RWD/RWE Strategy Planning and Governance
Subject Matter Experts (SME)
Operational and Data Coordinating Centre
Support for Clinical/Patient Registry Programs
Therapeutic/Disease-Specific Common Data Elements
Meta-Data Driven Data Harmonization and System Interoperability
AI/ML Driven Real-Time Analytics
RWD/RWE Data Insights and Statistical Modelling
We Provide Extensive Post Marketing Support Based On your Unique Needs

Brochure
Efficient Clinical Trials: Real-Time Oversight & Insights
Brochure
Real World Evidence (RWE) & Real-World Data (RWD) Services
ARTICLE
Key Takeaways From The FDA Guidance On DCTs
An overview of the guidance provided by USFDA on decentralized clinical trials
Trust Navitas for advanced Post Marketing services that drive clinical trial success

Experience
400+ NIS Studies

Expertise

Technology

Approach

Processes

Quality
Gain the Navitas Life Sciences Edge

Holistic Approach

8 Offices World Wide
Including 4 delivery centers across the globe.

Specialized Focus

Strategic Support
